Clinical Trials Browser

Phase 2 × Microsatellite Instability × tremelimumab × Clear all

NCT04817826 2025-06-10

INFINITY

Phase 2 Active not recruiting

Gastrointestinal

Stomach Neoplasms, Microsatellite Instability